Project timeline: June 20th – August 2022, 6-8 weeks Who you are: A graduate or professional student (i.e. PhD, MD, PharmD, MBA, MS), postdoc, clinical resident, or recent graduate Enthusiastic about gaining life-science business experience and helping a client identify how to have the most patient-health impact with their therapeutic Eager to build teamwork and […]

The Venture Advisors group at BCBA is seeking exceptional candidates to join our current teams. Work with other top tier multi-institutional colleagues to conduct due diligence on life science & healthcare startups for venture capital clients.

The client specializes in high-resolution detection of small target gene panels. Recently, the client acquired a complementary technology to offer high-throughput detection of genes with their platform.

You will be working with an early-stage startup founded by Caltech scientists, whose long-term vision is to become the standard of care for IVF. The founders’ mission is to improve the embryo selection process through a new embryo evaluation technology and to eventually enable embryo-rescuing interventions through early detection of poor outcomes. You and the BCBA team will help set the company’s directions by helping them craft their business plan and prepare to raise their Series A funding.

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]

Who we are: BCBA connects academic science trainees and recent graduates to the Bay Area’s biotech industry through hands-on consulting and due diligence projects. We are a volunteer organization composed of PhD students, post-docs, medical trainees, and young professionals looking to gain professional development skills for jobs in biotech companies, consulting, and venture capital. Over […]